Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AdvisorShares Psychedelics ETF PSIL

The AdvisorShares Psychedelics ETF (the Fund) seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or... see more

Recent & Breaking News (ARCA:PSIL)

    AdvisorShares Announces Reverse Split of ETF

    PR Newswire August 30, 2024

    AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX)

    PR Newswire August 24, 2022

    Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF

    GlobeNewswire October 1, 2021

    Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund (ETF)

    GlobeNewswire September 23, 2021

    Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF

    GlobeNewswire September 21, 2021

    Small Pharma Included in AdvisorShares® Newly Launched Psychedelics ETF

    GlobeNewswire September 20, 2021